Companies / Ligand Pharmaceuticals Inc / Activity
Activity — Ligand Pharmaceuticals Inc
110 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 14, 2026 | Davis Todd C CEO | Other | Common Stock | $2.87M | -16K -7.30% | 197,985 0.99% of shares | low |
| Feb 14, 2026 | Davis Todd C CEO | Other | Common Stock | $1.50M | -8K -4.49% | 173,941 0.87% of shares | low |
| Jun 11, 2026 | Aryeh Jason Director | Sell | Common Stock | $1.13M | -5K -4.20% | 102,580 0.51% of shares | medium |
| Jun 10, 2026 | Lamattina John L Director | Sell | Common Stock | $856.8K | -3K -11.21% | 26,969 0.14% of shares | medium |
| Feb 14, 2026 | Espinoza Octavio Executive | Other | Common Stock | $824.1K | -4K -10.93% | 36,531 0.18% of shares | low |
| Feb 15, 2026 | Davis Todd C CEO | Other | Common Stock | $782.2K | -4K -2.17% | 191,691 0.96% of shares | low |
| Feb 14, 2026 | Reardon Andrew Executive | Other | Common Stock | $750.6K | -4K -9.42% | 39,255 0.20% of shares | low |
| Mar 4, 2026 | Espinoza Octavio Executive | Sell | Common Stock | $712.6K | -3K -13.61% | 21,662 0.11% of shares | medium |
| Feb 14, 2026 | Espinoza Octavio Executive | Other | Common Stock | $691.4K | -4K -10.46% | 32,204 0.16% of shares | low |
| Mar 11, 2026 | Espinoza Octavio Executive | Sell | Common Stock | $687.8K | -3K -12.70% | 21,010 0.11% of shares | medium |
| Feb 14, 2026 | Reardon Andrew Executive | Other | Common Stock | $590.3K | -3K -8.51% | 34,528 0.17% of shares | low |
| Feb 15, 2026 | Davis Todd C CEO | Other | Common Stock | $515.6K | -3K -1.46% | 188,886 0.95% of shares | low |
| Mar 4, 2026 | Espinoza Octavio Executive | Sell | Common Stock | $510.8K | -2K -8.92% | 25,075 0.13% of shares | medium |
| Mar 6, 2026 | Lamattina John L Director | Sell | Common Stock | $433.8K | -2K -6.57% | 30,724 0.15% of shares | medium |
| Mar 3, 2026 | Sabba Stephen L Director | Sell | Common Stock | $409.9K | -2K -5.68% | 33,793 0.17% of shares | medium |
| Feb 15, 2026 | Davis Todd C CEO | Other | Common Stock | $374.8K | -2K -1.03% | 195,946 0.98% of shares | low |
| May 13, 2026 | Kozarich John W Director | Sell | Common Stock | $352.0K | -2K -3.63% | 41,786 0.21% of shares | medium |
| Mar 4, 2026 | Espinoza Octavio Executive | Sell | Common Stock | $328.5K | -2K -5.45% | 27,532 0.14% of shares | medium |
| Mar 4, 2026 | Reardon Andrew Executive | Sell | Common Stock | $300.9K | -1K -3.66% | 38,011 0.19% of shares | medium |
| Mar 4, 2026 | Espinoza Octavio Executive | Sell | Common Stock | $299.8K | -1K -4.76% | 29,120 0.15% of shares | medium |
| Mar 4, 2026 | Reardon Andrew Executive | Exercise | Common Stock | $261.4K | +5K +13.56% | 41,869 0.21% of shares | low |
| Mar 6, 2026 | Lamattina John L Director | Exercise | Common Stock | $246.7K | +2K +7.03% | 32,885 0.16% of shares | low |
| Mar 4, 2026 | Reardon Andrew Executive | Sell | Common Stock | $238.5K | -1K -3.00% | 36,869 0.18% of shares | medium |
| Feb 15, 2026 | Espinoza Octavio Executive | Other | Common Stock | $233.5K | -1K -3.70% | 33,012 0.17% of shares | low |
| Feb 15, 2026 | Espinoza Octavio Executive | Other | Common Stock | $224.8K | -1K -3.44% | 34,282 0.17% of shares | low |
| Mar 11, 2026 | Espinoza Octavio Executive | Exercise | Common Stock | $222.8K | +2K +11.10% | 24,067 0.12% of shares | low |
| Mar 23, 2026 | Sabba Stephen L Director | Sell | Common Stock | $207.9K | -1K -2.96% | 32,793 0.16% of shares | medium |
| Mar 4, 2026 | Espinoza Octavio Executive | Sell | Common Stock | $191.6K | -950 -2.82% | 32,685 0.16% of shares | medium |
| Feb 15, 2026 | Espinoza Octavio Executive | Other | Common Stock | $188.6K | -1K -2.81% | 35,505 0.18% of shares | low |
| Feb 15, 2026 | Reardon Andrew Executive | Other | Common Stock | $182.4K | -992 -2.62% | 36,869 0.18% of shares | low |
| Jun 10, 2026 | Lamattina John L Director | Sell | Common Stock | $173.9K | -697 -2.24% | 30,374 0.15% of shares | medium |
| Mar 4, 2026 | Espinoza Octavio Executive | Sell | Common Stock | $152.1K | -743 -2.37% | 30,577 0.15% of shares | medium |
| Feb 15, 2026 | Reardon Andrew Executive | Other | Common Stock | $147.2K | -801 -2.07% | 37,861 0.19% of shares | low |
| Mar 3, 2026 | Sabba Stephen L Director | Exercise | Common Stock | $141.4K | +2K +6.02% | 35,827 0.18% of shares | low |
| Mar 4, 2026 | Espinoza Octavio Executive | Sell | Common Stock | $141.3K | -697 -2.13% | 31,988 0.16% of shares | medium |
| Mar 4, 2026 | Espinoza Octavio Executive | Sell | Common Stock | $140.4K | -698 -2.03% | 33,635 0.17% of shares | medium |
| Mar 4, 2026 | Espinoza Octavio Executive | Sell | Common Stock | $138.9K | -699 -1.99% | 34,386 0.17% of shares | medium |
| Mar 4, 2026 | Espinoza Octavio Executive | Sell | Common Stock | $136.0K | -668 -2.09% | 31,320 0.16% of shares | medium |
| Mar 4, 2026 | Reardon Andrew Executive | Sell | Common Stock | $126.7K | -612 -1.53% | 39,457 0.20% of shares | medium |
| Jun 10, 2026 | Aryeh Jason Director | Sell | Common Stock | $125.0K | -500 -0.46% | 107,080 0.54% of shares | medium |
| May 13, 2026 | Kozarich John W Director | Exercise | Common Stock | $109.5K | +2K +3.77% | 43,361 0.22% of shares | low |
| Feb 15, 2026 | Reardon Andrew Executive | Other | Common Stock | $109.0K | -593 -1.51% | 38,662 0.19% of shares | low |
| May 12, 2026 | Kozarich John W Director | Sell | Common Stock | $102.8K | -459 -1.09% | 41,786 0.21% of shares | medium |
| Mar 4, 2026 | Reardon Andrew Executive | Sell | Common Stock | $94.4K | -460 -1.13% | 40,409 0.20% of shares | low |
| Mar 4, 2026 | Espinoza Octavio Executive | Exercise | Common Stock | $94.0K | +2K +4.87% | 34,619 0.17% of shares | low |
| Feb 2, 2026 | Kozarich John W Director | Sell | Common Stock | $74.8K | -381 -0.87% | 43,210 0.22% of shares | low |
| Mar 4, 2026 | Reardon Andrew Executive | Sell | Common Stock | $70.2K | -340 -0.84% | 40,069 0.20% of shares | low |
| Jun 10, 2026 | Lamattina John L Director | Sell | Common Stock | $63.5K | -257 -0.81% | 31,303 0.16% of shares | low |
| Mar 4, 2026 | Reardon Andrew Executive | Sell | Common Stock | $60.5K | -300 -0.73% | 41,069 0.21% of shares | low |
| Jun 10, 2026 | Lamattina John L Director | Sell | Common Stock | $57.6K | -232 -0.74% | 31,071 0.16% of shares | low |